Case report: Therapeutic response for new daily persistent headache by a tumor necrosis factor alpha antagonist, lithium

• Main Authors: Ernesto M Bancalari (Author), Astrid Wicht (Author)
• פורמט: ספר
• יצא לאור: SAGE Publishing, 2021-03-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

New daily persistent headache (NDPH) is an uncommon, treatment-resistant primary headache disorder that was first describe by Vanast in 1986 as a benign syndrome. Elevated TNF-alpha levels on CSF of NDPH patients as a possible cause of this disease. TNF-alpha inhibitors like doxycycline, venlafaxine...